92 related articles for article (PubMed ID: 12321668)
1. Chemoprevention and prostate cancer.
Crawford ED
Fam Urol; 1997; ():14-5. PubMed ID: 12321668
[TBL] [Abstract][Full Text] [Related]
2. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
3. Vasectomy and prostate cancer. Expert panel recommends no change in clinical practice.
Contracept Technol Update; 1993 May; 14(5):69-73. PubMed ID: 12345150
[TBL] [Abstract][Full Text] [Related]
4. Experts advise no change in vasectomy practice: prostate cancer link doubtful.
Harper PB
AVSC News; 1993 Jul; 31(2):1, 7. PubMed ID: 12318288
[TBL] [Abstract][Full Text] [Related]
5. The missing link: cutting through the vasectomy / prostate cancer scare.
Diconsiglio JM
Family Plan World; 1993; 3(5):12-3. PubMed ID: 12319136
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
Pathak SK; Sharma RA; Mellon JK
Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer link to vasectomy is weak.
Contracept Technol Update; 1998 Mar; 19(3):31. PubMed ID: 12293271
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
9. [Nutrition and pharmacological treatment for prevention of prostate cancer].
Segev Y; Nativ O
Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
[TBL] [Abstract][Full Text] [Related]
10. Does vasectomy cause prostate cancer?
Consum Rep Health; 1994 Jan; 6(1):8-9. PubMed ID: 12346121
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
12. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
13. Update on vasectomy.
Shannon M
CCL Family Found; 1994; 20(4):6-7. PubMed ID: 12345948
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
15. An update on chemoprevention strategies in prostate cancer for 2006.
Neill MG; Fleshner NE
Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
[TBL] [Abstract][Full Text] [Related]
16. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
Cussenot O; Azzouzi AR; Nicolaiew N; Mangin P; Cormier L; Fournier G; Valeri A; Cancel-Tassin G
Eur Urol; 2007 Oct; 52(4):1082-7. PubMed ID: 17448593
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention strategies for prostate cancer.
Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
[TBL] [Abstract][Full Text] [Related]
18. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II.
Moyad MA
Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864
[TBL] [Abstract][Full Text] [Related]
19. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I.
Moyad MA
Urol Oncol; 2004; 22(6):466-71. PubMed ID: 15610863
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Meuillet E; Stratton S; Prasad Cherukuri D; Goulet AC; Kagey J; Porterfield B; Nelson MA
J Cell Biochem; 2004 Feb; 91(3):443-58. PubMed ID: 14755676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
